Literature DB >> 10226567

Radical modulation activity of pine cone extracts of Pinus elliottii var. Elliottii.

K Satoh1, T Kihara, Y Ida, H Sakagami, N Koyama, M Premanathan, R Arakaki, H Nakashima, N Komatsu, M Fujimaki, Y Misawa, N Hata.   

Abstract

The radical modulation activity of lignins prepared from the cone of Pinus elliottii var. Elliottii was investigated, using ESR spectroscopy. These lignins produced radical(s) under alkaline conditions, and the radical intensity was increased with increasing pH. Lower concentrations of lignins slightly reduced the radical intensity of sodium ascorbate, whereas higher concentrations of lignins enhanced both the radical intensity and cytotoxic activity of sodium ascorbate. Lignins effectively scavenged superoxide anion, produced by hypoxanthine-xanthine oxidase reaction. Elliottii lignins significantly inhibited the human immunodeficiency virus (HIV)-induced cytopathic effect, in similar fashions to other natural, commercial and synthetic lignins. Pretreatment of mice with lignins significantly protected them from the lethal infection with E. coli. Crude alkaline extracts of Elliottii pine cone displayed similar magnitude of activity with lignins. These data further supports the medicinal efficacy of plant extracts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226567

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Potent anti-HIV activities and mechanisms of action of a pine cone extract from Pinus yunnanensis.

Authors:  Xuan Zhang; Liu-Meng Yang; Guang-Ming Liu; Ya-Juan Liu; Chang-Bo Zheng; Yong-Jun Lv; Hao-Zhi Li; Yong-Tang Zheng
Journal:  Molecules       Date:  2012-06-06       Impact factor: 4.411

2.  An orally active immune adjuvant prepared from cones of Pinus sylvestris, enhances the proliferative phase of a primary T cell response.

Authors:  William Guy Bradley; Katharine Nichole Holm; Akiko Tanaka
Journal:  BMC Complement Altern Med       Date:  2014-05-22       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.